Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000972891 | SCV000719575 | likely benign | not provided | 2021-02-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000972891 | SCV001120620 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002350473 | SCV002647472 | benign | Cardiovascular phenotype | 2019-03-08 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV000972891 | SCV005213358 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004544741 | SCV004759898 | likely benign | ALPK3-related disorder | 2019-04-11 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |